11 unchanged sentences
Purchased Under
−Removed: April 1, 2022 - April 30, 2022 28,809 (1)
+Added: July 1, 2022 - July 31, 2022 893 (1)
— $1,393,714,917
−Removed: May 1, 2022 - May 31, 2022 839 (1)
+Added: August 1, 2022 - August 30, 2022 1,023 (1)
— $1,393,714,917
−Removed: June 1, 2022 - June 30, 2022 989 (1)
+Added: September 1, 2022 - September 30, 2022 1,052 (1)
— $1,393,714,917
1 unchanged sentence
— $1,393,714,917
−Removed: In addition to AbbVie shares repurchased on the open market under a publicly announced program, if any, these shares also included the shares purchased on the open market for the benefit of participants in the AbbVie Employee Stock Purchase Plan – 28,809 in April;
−Removed: and 989 in June.
+Added: In addition to AbbVie shares repurchased on the open market under a publicly announced program, if any, these shares also included the shares purchased on the open market for the benefit of participants in the AbbVie Employee Stock Purchase Plan – 893 in July;
+Added: 1,023 in August;
+Added: and 1,052 in September.
These shares do not include the shares surrendered to AbbVie to satisfy minimum tax withholding obligations in connection with the vesting or exercise of stock-based awards.
2 unchanged sentences
Exhibit Description
−Removed: AbbVie Non-Employee Directors’ Fee Plan, as amended and restated *
+Added: *Form of Agreement Regarding Change in Control by and between AbbVie Inc.
+Added: and its named executive officers (incorporated by reference to Exhibit 10.1 to the company's Current Report on Form 8-K filed on October 14, 2022).**
+Added: AbbVie Deferred Compensation Plan Plus.**
Certification of Chief Executive Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).
5 unchanged sentences
101 The following financial statements and notes from the AbbVie Inc.
−Removed: Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, filed on August 4, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed on November 4, 2022, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) Condensed Consolidated Statements of Earnings;
7 unchanged sentences
_______________________________________________________________________________
+Added: * Incorporated herein by reference.
+Added: Commission file number 001-35565.
** Denotes management contract or compensatory plan or arrangement required to be filed as an exhibit hereto.
3 unchanged sentences
Chief Financial Officer (Principal Financial Officer)
−Removed: August 4, 2022
+Added: November 4, 2022
2022 Form 10-Q |
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.